These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2942244)

  • 21. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
    Murren J; Modiano M; Clairmont C; Lambert P; Savaraj N; Doyle T; Sznol M
    Clin Cancer Res; 2003 Sep; 9(11):4092-100. PubMed ID: 14519631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group Study.
    Whitlock JA; Krailo M; Reid JM; Ruben SL; Ames MM; Owen W; Reaman G;
    J Clin Oncol; 2005 Dec; 23(36):9179-86. PubMed ID: 16361620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
    Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C
    Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase II evaluation of menogaril in patients with advanced hypernephroma.
    Long HJ; Hauge MD; Therneau TM; Buckner JC; Frytak S; Hahn RG
    Invest New Drugs; 1991 Aug; 9(3):261-2. PubMed ID: 1838363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I trial of mitoxantrone by 24-hour continuous infusion.
    Anderson KC; Garnick MB; Meshad MW; Cohen GI; Pegg WJ; Frei E; Israel M; Modest E; Canellos GP
    Cancer Treat Rep; 1983 May; 67(5):435-8. PubMed ID: 6850662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase I and pharmacological study of protracted infusions of crisnatol mesylate in patients with solid malignancies.
    Villalona-Calero MA; Petit T; Kuhn J; Cobb P; Kraynak M; Eckhardt SG; Drengler R; Simmons C; Santabarbara P; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 1999 Nov; 5(11):3369-78. PubMed ID: 10589747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I study of triglycidylurazol given on a 5-day i.v. schedule.
    Nicaise C; Rozencweig M; Crespeigne N; Dodion P; Gerard B; Lambert M; Decoster G; Kenis Y
    Cancer Treat Rep; 1986 May; 70(5):599-603. PubMed ID: 3708609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I trial of ICRF-187 by 48-hour continuous infusion.
    Koeller JM; Earhart RH; Davis HL
    Cancer Treat Rep; 1981; 65(5-6):459-63. PubMed ID: 6786740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy.
    Long HJ; Schaid DJ; Schutt AJ; Ingle JN; Loprinzi CL; Edmonson JH
    Am J Clin Oncol; 1988 Oct; 11(5):524-7. PubMed ID: 2972192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.
    Goss G; Siu LL; Gauthier I; Chen EX; Oza AM; Goel R; Maroun J; Powers J; Walsh W; Maclean M; Drolet DW; Rusk J; Seymour LK;
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):703-10. PubMed ID: 16528532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
    Gundersen S; Monfardini S; Renard G; Van Glabbeke M; Pinedo H
    Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1707-8. PubMed ID: 2962875
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of menogaril in patients with metastatic sarcomas and no prior chemotherapy exposure.
    Buckner JC; Edmonson JH; Ingle JN; Schaid DJ
    Am J Clin Oncol; 1989 Oct; 12(5):384-6. PubMed ID: 2529759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I study of bendamustine hydrochloride administered once every 3 weeks in patients with solid tumors.
    Rasschaert M; Schrijvers D; Van den Brande J; Dyck J; Bosmans J; Merkle K; Vermorken JB
    Anticancer Drugs; 2007 Jun; 18(5):587-95. PubMed ID: 17414628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel administered by a 1-hour infusion: A phase I-II trial comparing two schedules.
    Hainsworth JD; Raefsky EL; Greco FA
    Cancer J Sci Am; 1995; 1(4):281-7. PubMed ID: 9166489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I clinical and pharmacologic trial of carboplatin daily for 5 days.
    Van Echo DA; Egorin MJ; Whitacre MY; Olman EA; Aisner J
    Cancer Treat Rep; 1984 Sep; 68(9):1103-14. PubMed ID: 6383605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of menogaril in renal cell carcinoma. A Southwest Oncology Group phase II study (8504).
    Stephens RL; Goodman P; Crawford ED; Spicer CF; Lowe BA; Ahmann FR; Chapman R; Natale RB
    Invest New Drugs; 1990; 8 Suppl 1():S69-71. PubMed ID: 2143177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.
    Egorin MJ; Van Echo DA; Whitacre MY; Forrest A; Sigman LM; Engisch KL; Aisner J
    Cancer Res; 1986 Mar; 46(3):1513-20. PubMed ID: 2935249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of i.v. menogaril in patients with malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group Study.
    McCulloch PB; Eisenhauer EA; Shibata HR; Young VP
    Cancer Treat Rep; 1987; 71(7-8):771-2. PubMed ID: 2955887
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase I trial of teroxirone.
    Neidhart JA; Derocher D; Grever MR; Kraut EH; Malspeis L
    Cancer Treat Rep; 1984 Sep; 68(9):1115-9. PubMed ID: 6478450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of menogaril as initial chemotherapy for metastatic breast cancer.
    Kennedy MJ; Donehower RC; Grochow LB; Ettinger DS; Fetting JH; Abeloff MD
    Invest New Drugs; 1990 Aug; 8(3):289-94. PubMed ID: 2148742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.